1199
R. H. Swellem et al. • Cinnamoylacetonitrile in Heterocyclic Synthesis, Part 7
Table II. Spectral data of the newly prepared compounds.
Compd.
No.
IR (cm *)
'H NMR-
d (ppm)
2200 (CN ), 1620 (C=N)
2.6 (dd, Jvic = 10Hz, Jgem= 15Hz, 1H, methylene H-axial), 3.0 (dd, Jvic =
6Hz, Jgem = 15Hz, 1H, methylene H-equatorial), 4.5 (s,2H,CH2CN), 4.7
(dd, Jvic} = 10Hz, Jvic2 = 6Hz, lH.methine H), 7.0-7.5 (m,9H,C6H5 and
benzothiazepine H-6 to H-9).
1700 ( CO )
2.4 (dd,Jvic = 10Hz, Jgem = 15Hz, 1H, methylene H-axial), 3.1 (dd,Jvic =
6Hz,Jgem = 15Hz, 1H, methylene H-equatorial), 4.4 (dd, Jvici = 10Hz,
Jvic2= 6Hz, 1H, methine H), 6.7-7.6 (m, 13H, C6H5, benzothiazepine H-
6 to H-9 and coumarin H-5 to H-8), 8.0 (s, 1H, coumarin H-4).
7.4-7.8 (m, 14H, C6H5, coumarin H-5 to H-8, benzothiazepine H-3 and
H-6 to H-9), 8.1 (s,lH, coumarin H-4).
4a
4b
6.6-6.8 (m, 2H, furan H-4, H-3), 7.0-8.1 (m, 10H, C6H4, benzothiazepine
H-3 , H-6 to H-9 and furan H-5).
4c
7a
6.9-8.0 (m, 15H, 2C6H5, benzothiazepine H-3, H-6 to H-9).
3.0 (dd, Jvic= 10Hz, Jgem = 15Hz, 1H, methylene H-axial), 3.4 (dd,Jvic=
6Hz, Jgem= 15Hz, 1H, methylene H equatorial), 5.5 (dd, Jvicl = 10Hz,
Jvic2 = 6Hz, 1H, methine H), 6.7 (dd, 1H, furanH-4), 7.1-8.0 (m, 10H,
C6H4, benzothiazepine, H-6 to H-9, furan H-3 and H-5).
2.7 (dd, Jvic = 10Hz, Jgem = 15Hz, 1H, methylene H-axial), 3.2 (dd,Jvic =
6Hz, Jgem = 15Hz, 1H, methylene H-equatorial), 5.1 (dd, Jvici= 10Hz,
Jvic2= 6Hz, 1H, methine H), 7.2-7.6 (m,14H,2C6H5and benzo-thiazepine
H-6 to H-9), 14.6 (s,lH,NH).
1640 (C=N)
3100-2800 (NH and ring
stretching), 2200 (CN)
2200 (CN), 1650 (CO)
2.9 (dd, Jvic = 10Hz, Jgem = 15Hz, 1H, methylene H-axial), 3.1 (dd, Jvic =
6Hz, Jgem = 15Hz, 1H, methylene H-equatorial), 4.9 (dd, Jvicl = 10Hz,
Jvic2= 6Hz, 1H, methine H), 5.4 (s, 2H, phenoxy-methylene), 7.1-7.7 (m,
12H, benzothiazepine H-6 to H-9,C6HSand C6H3), 12.4 (s,lH ,OH).
3.7-3.8 (2s,9H, 30CH3), 7.1 (s,2H,C6H2), 7.3-7.6 (m,6H,C6H5and pyron
H-5).
10a
2200 (CN), 1685 (CO)
10b
11
2200 (CN), 1680 (CO)
3100-2800 (NH and OH),
2200 (CN)
5.4 (s, 2H, phenoxy CH2), 7.4-7.7 (m, 9H, C6H5, C6H3 and pyron H-5).
3.2 (m, 2H, pyrrolidine CH2), 5.1 (s, 1H, NH), 6.1(m, lH, pyrrolidine H-
5), 7.4-7.6 (m,5H, C6H5), 8.5 (s, lH,OH).
13
14
3400-3200 (NH2), 1710 (CO)
7.2 (d, J = 15H, 1H, olefinic H-l), 7.4-7.6 (m,5H, C6H5), 8.0 (d, J = 15Hz,
1H. olefinic H-2), 8.7 (s, 1H, oxazole H-2).
7.4-7.6 (m, 5H, C6H5), 8.2 (s,lH, oxazolopyridine H-2), 8.4 (s, 1H, oxazo-
lopyridine H-5), 11.6 (s,lH, NH).
3300 (NH), 1690 (CO)
was obtained with
a
molecular formula
obtained gave a molecular formula C11H 10N2O
m/z (M+186); it showed OH, CN and NH absorp-
C12H 10N2O2 m/z (M+214). It lacked the CN ab-
tions together with two signals at
6.1 (1H) ppm. Accordingly, the pyrrolidinone
structure of 11 was assigned to this product.
d 3.2 (2H) and sorption, detected in the parent oxime, and
d
showed CO and NH2 absorptions at 1710 and
3400-3200 cm-1. WTiile its !H NMR revealed two
When the same reaction was repeated using doublets at <57.2 and
d 8.0 ppm, similar to those
98% HCOOH instead of 50%, a different product present in the parent oxime and attributed to the
olefinic protons. So, the cinnamoyloxazole struc-
ture 13 was given to this product. This could be
explained via initial reduction to form the 2-
aminopentenenitrile, followed by its formylation
n h 2
c
n
rA
') oxim e
t
jj) Sn
h^JLcN
HNCHO
12
Ä
form ation
9 8 % HCOOH
P
h
V
R
NaH
to afford the intermediate 12 which undergoes in-
tracyclization via its enol form and the CN group
to the final isolable product 13. While in presence
of 50% HCOOH, the reduction step is followed
by intracyclization (NH2 group and olefinic double
bond) to form 11. The structure of 13 was also
13
ii) Sn
OCHj
Ph
10a,R = — < ^ ~ ^ -0CH 3
Q=<^~^NH
o c h 3
N~0
b ,R
=
^
0 ^
I
^
CI
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 7/19/15 1:14 PM